中西醫(yī)結(jié)合治療對Graves病患者外周血T、B淋巴細胞亞群的影響
發(fā)布時間:2018-02-23 16:40
本文關(guān)鍵詞: 格雷夫斯病 淋巴細胞 協(xié)同刺激分子 中藥 出處:《山東大學學報(醫(yī)學版)》2007年08期 論文類型:期刊論文
【摘要】:目的:研究中西醫(yī)結(jié)合治療對Graves病患者外周血T、B淋巴細胞亞群及部分協(xié)同刺激分子表達的影響。方法:運用流式細胞術(shù)測定20例Graves病初發(fā)患者、11例他巴唑治療患者(西藥組)、16例他巴唑合用中藥五岳抗甲丸治療患者(中西醫(yī)結(jié)合組)及16例正常對照外周血淋巴細胞CD19、CD40、CD80、CD3、CD4、CD8、CD28等分子的表達水平。結(jié)果:Graves病初發(fā)患者CD19+、CD40+、CD19+CD40+、CD80+細胞比率高于正常對照組(P0.01或P0.05),CD3+CD8+細胞比率降低(P0.05),CD3+CD4+/CD3+CD8+比值高于正常對照(P0.05);西藥組患者CD80+細胞恢復正常,CD3+CD4+細胞比率及CD3+CD4+/CD3+CD8+比值高于正常對照(P0.05,P0.01),而CD3+CD8+及CD8+CD28+細胞比率低于正常對照(P0.01,P0.05);除CD80+細胞比率高于正常對照外,中西醫(yī)結(jié)合組所測各種分子的表達同正常對照組比較,差異無統(tǒng)計學意義;同西藥組比較,中西醫(yī)結(jié)合組CD3+CD4+細胞降低(P0.01),CD3+CD8+及CD8+CD28+細胞比率升高(P0.01,P0.05),CD3+CD4+/CD3+CD8+比值降至正常水平(P0.01)。結(jié)論:Graves病患者體液免疫處于較高水平,存在細胞免疫調(diào)節(jié)失衡,中西醫(yī)結(jié)合治療較單純西藥治療更有利于患者免疫狀態(tài)的恢復。
[Abstract]:Objective: to study the effect of integrated traditional Chinese and western medicine on the expression of Thunb lymphocyte subsets and partial co-stimulatory molecules in peripheral blood of patients with Graves disease. Methods: flow cytometry was used to determine the expression of Thunb lymphocyte subsets and partial costimulatory molecules in peripheral blood of 20 patients with Graves disease. The expression level of CD19, CD40, CD40, CD40, CD80, CD3, CD4, CD8, CD8, CD28, and other molecules in peripheral blood lymphocytes of patients with primary Graves disease were studied. The ratio of P0.01 or P0.05C / CD3 CD8 cells in the western medicine group was higher than that in the normal control group, and the ratio of CD80 cells to normal CD4 cells and CD3 CD4 / CD3 CD8 ratio in the western medicine group was higher than that in the normal control group, while the ratio of CD3 CD8 and CD8 CD28 was higher than that of the normal control group. The percentage of CD80 cells was lower than that of normal controls, except that the ratio of CD80 cells was higher than that of normal controls. Compared with the normal control group, the expression of various molecules measured in the integrated Chinese and western medicine group was not significantly different from that in the western medicine group. The ratio of CD3 CD4 cells and CD8 CD28 cells decreased to a normal level. Conclusion the humoral immunity of patients with CD3's disease is at a higher level, and the cellular immune regulation is out of balance. Integrated Chinese and western medicine treatment is more conducive to the recovery of patients' immune state than western medicine alone.
【作者單位】: 山東大學山東省立醫(yī)院中心實驗室 山東大學山東省立醫(yī)院中心實驗室 山東大學山東省立醫(yī)院保健科 山東大學山東省立醫(yī)院中心實驗室 山東大學山東省立醫(yī)院中心實驗室 山東大學山東省立醫(yī)院中心實驗室 山東大學山東省立醫(yī)院中心實驗室 山東大學山東省立醫(yī)院中心實驗室 山東大學山東省立醫(yī)院內(nèi)分泌科
【基金】:山東省科技廳科技攻關(guān)課題(2003-33) 山東省中醫(yī)藥管理局科研基金資助課題(2005-070)
【分類號】:R581.1
【參考文獻】
相關(guān)期刊論文 前3條
1 陳蕾,沈華英,吳敏,於葛華,邱玉華,周照華,張學光;Graves病患者外周血T細胞亞群和共刺激分子的表達及其意義[J];上海免疫學雜志;2002年01期
2 趙家軍,高 聆,柳欣琦,劉雪萍;Preliminary Study on Chinese Drug-Induced Apoptosis of Thyrocytes in Graves' Disease[J];Chinese Journal of Integrated Traditional and Western Medicine;2000年03期
3 高聆,劉春雨,孔祥輝,趙家軍,馮建華;中藥五岳抗甲丸對格利夫氏病患者血清粘附分子及甲狀腺功能的影響[J];中國中西醫(yī)結(jié)合雜志;2002年10期
【共引文獻】
相關(guān)期刊論文 前7條
1 李松坡;甲狀腺功能亢進癥中西醫(yī)研究進展[J];黑龍江中醫(yī)藥;2004年04期
2 孫治平;張學光;;CD4~+ CD28~- T淋巴細胞與自身免疫性疾病[J];現(xiàn)代免疫學;2006年04期
3 孫治平;陳蕾;淤葛華;朱一蓓;仲維學;施畢e,
本文編號:1526868
本文鏈接:http://sikaile.net/yixuelunwen/zhxiyjh/1526868.html
最近更新
教材專著